UNITY Biotechnology, Inc. UNBX
0.06
0.00
0.00%
as of 14 Oct
- Market cap
- $3.4M
- P/E
- 0.0×
Follow UNBX
Growth Flags
show if company had growth for consecutive years
| Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | 0.00 | 0.00 | — | — | — | 0.00 | — |
P/S ratio |
— | — | 0.00 | 0.00 | — | — | — | 0.00 | — |
P/FCF ratio |
— | — | 0.00 | 0.00 | — | — | — | 0.00 | — |
P/Operating CF |
— | — | (2.39) | (16.21) | — | — | — | (4.82) | — |
P/B ratio |
— | — | 0.50 | 1.37 | — | — | — | 0.00 | — |
Price to Tangible BV |
— | — | 0.50 | 1.37 | — | — | — | 0.00 | — |
EV/Sales |
— | — | 0.00 | 0.00 | — | — | — | 0.00 | — |
EV/EBITDA |
— | — | 0.85 | 0.00 | — | — | — | 1.50 | — |
EV/Operating CF |
— | — | 0.88 | (0.33) | — | — | — | 1.81 | — |
EV/FCF |
— | — | 0.89 | (0.33) | — | — | — | 1.75 | — |
Quick Ratio |
2.51 | 5.51 | 4.83 | 5.30 | 6.76 | 7.09 | 10.32 | 11.13 | 24.19 |
Current Ratio |
2.62 | 5.94 | 4.92 | 5.45 | 6.97 | 7.52 | 10.43 | 11.25 | 25.31 |
Net Debt/EBITDA |
0.82 | 1.12 | 1.37 | 1.28 | 0.79 | 1.38 | 2.19 | 1.96 | 4.78 |
Debt/Assets |
0.00% | 0.00% | 16.38% | 17.21% | 18.57% | 0.03% | 0.07% | 0.20% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.36 | 0.36 | 0.35 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 |
Operating CF/Net income |
0.80 | 0.93 | 1.18 | 0.74 | 0.83 | 0.88 | 0.74 | 0.86 | 0.54 |
Capex/Depreciation |
0.01 | 0.02 | 0.09 | (0.04) | (0.10) | (1.05) | (1.03) | (1.14) | (14.67) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (148.97%) | (94.36%) | (76.90%) | (85.26%) | (92.19%) | (58.41%) | (196.95%) | 71.77% | 48.94% | |
| (50.29%) | (41.95%) | (35.71%) | (43.22%) | (61.03%) | (49.42%) | (53.92%) | (87.54%) | (30.55%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | (413.16%) | 0.00% | 0.00% | (628.56%) | 0.00% |
Return on Tangible Assets |
(140.77%) | (90.91%) | (52.48%) | (72.44%) | (94.76%) | (63.75%) | (46.98%) | (50.78%) | (33.06%) |
Average Days of Receivables |
— | — | 0.00 | 0.00 | — | — | — | 365.00 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 15,618.22% | 802.53% | 0.00% | 0.00% | 0.00% | 2,704.27% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 8,876.69% | 481.94% | 0.00% | 0.00% | 0.00% | 695.88% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 3,974.15% | 241.49% | 0.00% | 0.00% | 0.00% | 219.54% | 0.00% |
Graham Net Nets |
— | — | 1.01 | 0.31 | — | — | — | 2.14 | — |
Graham Number |
— | — | 0.00 | 0.00 | — | — | — | 903.62 | — |
Earnings Yield |
— | — | (238.51%) | (74.66%) | — | — | — | (94.62%) | — |
Free Cash Flow Yield |
— | — | (185.53%) | (55.53%) | — | — | — | (76.67%) | — |
Revenue per Share |
0.00 | 0.00 | 0.02 | 0.86 | 0.00 | 0.00 | 0.00 | 4.32 | 0.00 |
Operating CF per Share |
(1.24) | (2.51) | (5.52) | (8.07) | (15.40) | (16.60) | (20.03) | (119.94) | (61.58) |
Capex per Share |
0.00 | 0.01 | 0.03 | (0.03) | (0.13) | (0.36) | (0.45) | (5.28) | (8.43) |
Free Cash Flow per Share |
(1.24) | (2.50) | (5.49) | (8.11) | (15.53) | (16.96) | (20.48) | (125.23) | (70.00) |
Cash per Share |
1.38 | 2.92 | 9.98 | 15.78 | 19.21 | 27.96 | 60.54 | 270.51 | 335.28 |
Shareholders Equity per Share |
0.39 | 1.92 | 5.91 | 10.67 | 16.30 | 27.67 | 56.84 | 284.06 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.39 | 1.92 | 5.91 | 10.67 | 16.30 | 27.67 | 56.84 | 284.06 | 0.00 |
Free Cash Flow |
(20.84) | (36.98) | (52.13) | (45.25) | (78.98) | (74.01) | (57.89) | (40.05) | (18.64) |
Working Capital |
15.01 | 38.77 | 76.92 | 73.89 | 86.40 | 112.27 | 156.38 | 80.98 | 89.72 |
Capital Expenditures |
0.03 | 0.10 | 0.28 | (0.19) | (0.65) | (1.59) | (1.26) | (1.69) | (2.24) |
Net Current Asset Value |
(6.90) | 9.31 | 28.27 | 25.36 | 27.43 | 98.97 | 152.28 | 77.70 | 93.41 |
EV/EBIT |
— | — | 0.80 | 0.00 | — | — | — | 1.45 | — |
Capex to Sales |
0.00 | 0.00 | (1.19) | 0.04 | 0.00 | 0.00 | 0.00 | 1.22 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | (18,842.80%) | (1,269.34%) | 0.00% | 0.00% | 0.00% | (3,231.26%) | 0.00% |
Price to Operating Income |
— | — | 0.00 | 0.00 | — | — | — | 0.00 | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.82 | 1.18 | 0.41 | 0.48 | 0.53 | 0.09 | 0.20 | 0.21 | 0.07 |
Cash ROIC |
(81.82%) | (58.90%) | (35.18%) | (32.52%) | (43.40%) | (36.69%) | (18.94%) | (25.52%) | (20.88%) |
Accounts Receivable Turnover |
— | — | 0.00 | 0.00 | — | — | — | 0.00 | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
Average Payables |
1.19 | 1.59 | 1.89 | 2.27 | 3.87 | 5.02 | 3.61 | 1.67 | 1.67 |
Average Assets |
51.68 | 95.02 | 124.53 | 140.52 | 153.77 | 166.30 | 141.70 | 51.01 | 99.54 |
Average Common Equity |
17.45 | 42.24 | 57.83 | 71.22 | 101.79 | 140.70 | 38.79 | (62.22) | (62.12) |
Columns are period end dates